Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1351.6000 7.20 (0.54%)
NSE Jun 16, 2026 15:31 PM
Volume: 719.4K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1351.60
0.54%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 75.81% in the last 3 Months
More from Rubicon Research Ltd.
Recommended
Five stocks to buy from analysts this week - June 16, 2026
The Baseline | 16 Jun 2026, 05:11PM
Market closes higher on easing oil prices and foreign fund inflows
Trendlyne Marketwatch | 16 Jun 2026, 03:55PM
IPO momentum continues with six new issues and three upcoming listings
| 15 Jun 2026, 04:48PM